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Background & objectives : Melioidosis and the causative organism Burkholderia pseudomallei are being
recognized gradually in various centres in India.  In the septicaemic form, melioidosis is a serious and
life threatening condition which requires early detection and specific treatment to avoid case fatality. A
review of patients with septicaemic melioidosis at a tertiary care hospital in south India was carried
out with a view to define the clinical features, predisposing conditions, if any, and the outcome.
Methods: A total of 28 patients with culture proven septicaemic melioidosis during December 1993 to
December 2002 were included. Information on clinical details and outcome was obtained and antibiotic
susceptibility of the isolates studied.
Results: Of the 28 patients of blood culture proven septicaemic melioidosis, the organism was also
isolated from pus in two patients. The presenting clinical features were varied, most presenting as
pyrexia of unknown origin or visceral abscesses, or septic arthiritis.  Associated/predisposing conditions
were present in 50 per cent of the patients, and diabetes mellitus was the commonest one.  The
mortality was 58 per cent in our series.
Interpretation & conclusion: Melioidosis is an emerging infection in India.  The magnitude of the
problem can only be assessed by increasing awareness, both of its existence in the clinical setting and
its identification in the laboratory.
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have confirmed melioidosis in a number of patients
with a variety of clinical presentations4-8.
The most serious form of the active infection is
an acute septicaemic illness which has a high
mortality rate.  The organism is usually resistant to
a variety of antimicrobial agents and the choice of
the correct antibiotic depends on the identification
of the microbe.  The illness is life-threatening and
the correct diagnosis and treatment are essential for
patient survival.  In this paper we review the
microbiological, clinical and epidemiological
observations in patients with septicaemic
Melioidosis has only recently been recognized in
India. The causative bacterium, B. pseudomallei is a
soil saprophyte, geographically restricted to certain
regions of the world.  Prior to 1992 there was only
indirect evidence of its presence in India.  When
melioidosis was diagnosed in two foreigners, one in
Scotland and the other in Germany, it was concluded
that they had acquired the infection while travelling
or working earlier in central or southern India 1 ,2. In
1991, culture-proven melioidosis was reported in a
child resident in Dapoli Taluka in Maharashtra3.
Since December 1993, when we first recognized
B. pseuodomallei in culture in our laboratory, we
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melioidosis, confirmed by the isolation of organisms
from blood culture.
Material & Methods
This study initially retrospective, has been carried
out in a prospective manner over the past seven years
at the Department of Clinical Microbiology,
Christian Medical College & Hospital, Vellore.
All blood culture B. pseudomallei positive
patients (28) seen during the period December 1993
till December 2002 were included. A conventional
method of blood culture was followed as described
earlier9 but during 2001 and 2002 the MINIVITAL
automation system (BioMerieux, India Private
Limited, Secunderabad) was in use.  Standard
methods were followed for identification of the
organism10. All isolates were serologically
confirmed using polyclonal antiserum raised in the
laboratory in rabbits.
The patients’ records were studied using a
proforma and information on age, sex, occupation,
State of origin, clinical details and outcome in terms
of fever defervescence, recovery, death collected.
Antibiotic susceptibility testing was carried out
by the disc diffusion method using standard
procedures11 with the following discs (concentration
µg/disc) ampicillin (10), cefotaxime (30),
ceftazidime (30), gentamicin (10), ciprofloxacin (5),
cotrimoxazole (25), imipenem (10).
Results & Discussion
During the study period, 98,369 samples were
received in the Department for blood cultures of
which 30 cultures from 28 patients grew
B. pseudomallei. A total of 40 isolates of
B. pseudomallei were obtained, 28 were from blood,
8 from pus, 3 from synovial fluid specimens and
one from sputum.
Although we had isolated the organism from
various clinical specimens in both male and female
patients, the blood isolates were only from men.  In
two patients the organism was isolated from pus as
well as blood.
The age of patients in whom this organism was
isolated from blood ranged from 9 to 65 yr (mean ±
SD, 44.67 ± 8.55 ). Although melioidosis has been
reported to be associated with certain occupations
such as rice farming and cattle farming12, there was
no significant association with any one occupation(s)
in our series.
We analysed the distribution of patients according
to the State of origin and found that patients came
from all the Indian states the maximum (10) being
from Tamil Nadu where our hospital is located.
Most (16) patients presented with pyrexia of
unknown origin (PUO) and serological,
haematological, radiological investigations did not
indicate any etiology; a routine blood culture grew
B. pseudomallei. Visceral abscesses in the spleen
and the liver with fever was the presenting finding
in five patients, pleural cavity in one patient and
septic arthritis (knee joint/ankle joint) in three
patients.  Two patients had chronic renal failure and
were on haemodialysis and awaiting transplant and
one was a post renal transplant recepient.
Associated/predisposing conditions were present
in 12 of the 28 patients. These were leukemia (2),
renal failure (3), and diabetes mellitus (8). One
patient had diabetes mellitus and renal failure. The
mortality in our series was 58 per cent.
Study of the antibiotic susceptibility pattern
(AST) of these isolates showed that all were
susceptible to ceftazidime, cotrimoxazole and
imipenem and resistant to ampicillin and gentamicin.
Susceptibility to ciprofloxacin was observed in
44 per cent of the strains; with regard to cefotaxime
69 per cent were susceptible and 31 per cent in the
intermediate range. Based on a confirmed culture
and AST report, parenteral ceftazidime was
administered as recommended13 followed by
contrimoxazole for 12 wk.  In the patients who
recovered, response to treatment in terms of average
time taken for defervescence of fever varied
(mean ± SD, 12.0±11.2 day). In the northern region
of Thailand melioidosis is the commonest form of
septicaemic illness14. It is also a common cause of
septicaemia in Malaysia and is accompanied by a
fairly high mortality15.  It is important to record the
presence of this infection in different parts of India;
this information will help in focusing attention on
this particular etiological agent.  That the prevalence
of this infection is under-recognised in India may be
surmised from the paucity of reports from centers in
India.  Information on its geographic prevalence and
clinical features will help in raising the ‘index of
suspicion’ of melioidosis in the minds of physicians
when they encounter septicaemic disease, especially
in the presence of predisposing factors.
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